Page last updated: 2024-08-21

2,6-dichloroindophenol and Acquired Metabolic Diseases, Brain

2,6-dichloroindophenol has been researched along with Acquired Metabolic Diseases, Brain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bross, P; Gomes, CM; Henriques, BJ; Lucas, TG; Ribeiro, JV	1

Other Studies

1 other study(ies) available for 2,6-dichloroindophenol and Acquired Metabolic Diseases, Brain

Article	Year
Potential complementation effects of two disease-associated mutations in tetrameric glutaryl-CoA dehydrogenase is due to inter subunit stability-activity counterbalance. Biochimica et biophysica acta. Proteins and proteomics, 2020, Volume: 1868, Issue:1 Topics: 2,6-Dichloroindophenol; Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; Glutaryl-CoA Dehydrogenase; Heterozygote; Humans; Models, Molecular; Mutation; Protein Conformation; Protein Subunits	2020

Article

Year

Potential complementation effects of two disease-associated mutations in tetrameric glutaryl-CoA dehydrogenase is due to inter subunit stability-activity counterbalance.

Biochimica et biophysica acta. Proteins and proteomics, 2020, Volume: 1868, Issue:1

Topics: 2,6-Dichloroindophenol; Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; Glutaryl-CoA Dehydrogenase; Heterozygote; Humans; Models, Molecular; Mutation; Protein Conformation; Protein Subunits

2020